256 related articles for article (PubMed ID: 10206118)
1. Immunochemotherapy with interferon-gamma and multidrug therapy for multibacillary leprosy.
Barral-Netto M; Santos S; Santos I; von Sohsten R; Bittencourt AL; Carvalho EM; Barral A; Waters M
Acta Trop; 1999 Mar; 72(2):185-201. PubMed ID: 10206118
[TBL] [Abstract][Full Text] [Related]
2.
Hungria EM; Bührer-Sékula S; Oliveira RM; Aderaldo LC; Pontes MAA; Cruz R; de Gonçalves HS; Penna MLF; Penna GO; Stefani MMA
Front Immunol; 2018; 9():915. PubMed ID: 29867930
[TBL] [Abstract][Full Text] [Related]
3. Lymphocyte proliferation, IFN-gamma production and limiting dilution analysis of T-cell responses to ICRC and Mycobacterium leprae antigens in leprosy patients.
Shinde SR; Chiplunkar SV; Butlin R; Samson PD; Deo MG; Gangal SG
Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):51-8. PubMed ID: 8326181
[TBL] [Abstract][Full Text] [Related]
4. Potential Role of CXCL10 in Monitoring Response to Treatment in Leprosy Patients.
Ferreira H; Mendes MA; de Mattos Barbosa MG; de Oliveira EB; Sales AM; Moraes MO; Sarno EN; Pinheiro RO
Front Immunol; 2021; 12():662307. PubMed ID: 34354699
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of multidrug therapy in multibacillary leprosy: a long-term follow-up of 34 multibacillary leprosy patients treated with multidrug regimens till skin smear negativity.
Shaw IN; Christian M; Jesudasan K; Kurian N; Rao GS
Lepr Rev; 2003 Jun; 74(2):141-7. PubMed ID: 12862255
[TBL] [Abstract][Full Text] [Related]
6. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B
Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
[TBL] [Abstract][Full Text] [Related]
7. Effect of rhuIFN-gamma treatment in multibacillary leprosy patients.
Sampaio EP; Malta AM; Sarno EN; Kaplan G
Int J Lepr Other Mycobact Dis; 1996 Sep; 64(3):268-73. PubMed ID: 8862260
[TBL] [Abstract][Full Text] [Related]
8. The response to chemotherapy of serum Mycobacterium leprae-specific antigen in multibacillary leprosy patients.
Roche PW; Britton WJ; Neupane KD; Failbus SS; Cho SN; Theuvenet WJ
Am J Trop Med Hyg; 1991 Jun; 44(6):702-8. PubMed ID: 1858971
[TBL] [Abstract][Full Text] [Related]
9. A follow-up study of multibacillary Hansen's disease patients treated with multidrug therapy (MDT) or MDT + immunotherapy (IMT).
Rada E; Ulrich M; Aranzazu N; Rodriguez V; Centeno M; Gonzalez I; Santaella C; Rodriguez M; Convit J
Int J Lepr Other Mycobact Dis; 1997 Sep; 65(3):320-7. PubMed ID: 9401484
[TBL] [Abstract][Full Text] [Related]
10. Long-term evaluation of immune status in leprosy patients undergoing multiple drug therapy.
Vu TT; Hoang TL; Nguyen DQ; Ho ML; Nguyen DH; Le TH; Dang DT; Nguyen QA; Le TP; Tran HK
Int J Lepr Other Mycobact Dis; 1994 Sep; 62(3):365-73. PubMed ID: 7963908
[TBL] [Abstract][Full Text] [Related]
11. OFLOXACIN multicentre trial in MB leprosy FUAM-Manaus and ILSL-Bauru, Brazil.
Cunha Mda G; Virmond M; Schettini AP; Cruz RC; Ura S; Ghuidella C; Viana Fdos R; Avelleira JC; Campos AA; Filho B
Lepr Rev; 2012 Sep; 83(3):261-8. PubMed ID: 23356027
[TBL] [Abstract][Full Text] [Related]
12. Induction of lepromin positivity following immuno-chemotherapy with Mycobacterium w vaccine and multidrug therapy and its impact on bacteriological clearance in multibacillary leprosy: report on a hospital-based clinical trial with the candidate antileprosy vaccine.
Sharma P; Kar HK; Misra RS; Mukherjee A; Kaur H; Mukherjee R; Rani R
Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):259-69. PubMed ID: 10575405
[TBL] [Abstract][Full Text] [Related]
13. Late relapses in leprosy patients in Brazil: 10-year post-trial of uniform multidrug therapy (U-MDT/CT-BR).
Penna GO; Pontes MAA; Talhari S; Gonçalves HS; Talhari C; Pessoa AS; Pedroza V; Bührer-Sékula S; Stefani MMA; Penna MLF
Braz J Infect Dis; 2024; 28(2):103745. PubMed ID: 38697216
[TBL] [Abstract][Full Text] [Related]
14. Nasal mucosa and skin of smear-positive leprosy patients after 24 months of fixed duration MDT: histopathological and microbiological study.
Ebenezer GJ; Job A; Abraham S; Arunthathi S; Rao PS; Job CK
Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):292-7. PubMed ID: 10575409
[TBL] [Abstract][Full Text] [Related]
15. Serum markers of treatment success in leprosy.
MacLean S; Stietenroth K; Prange H; Pai VV; Ganapati R
Int J Lepr Other Mycobact Dis; 1999 Mar; 67(1):19-23. PubMed ID: 10407625
[TBL] [Abstract][Full Text] [Related]
16. Clinical oxidative stress during leprosy multidrug therapy: impact of dapsone oxidation.
Schalcher TR; Borges RS; Coleman MD; Batista Júnior J; Salgado CG; Vieira JL; Romão PR; Oliveira FR; Monteiro MC
PLoS One; 2014; 9(1):e85712. PubMed ID: 24465659
[TBL] [Abstract][Full Text] [Related]
17. Relapse with multibacillary leprosy caused by rifampicin sensitive organisms following paucibacillary multidrug therapy.
Soares DJ; Neupane K; Britton WJ
Lepr Rev; 1995 Sep; 66(3):210-3. PubMed ID: 7500815
[TBL] [Abstract][Full Text] [Related]
18. Uniform multidrug therapy for leprosy patients in Brazil (U-MDT/CT-BR): Results of an open label, randomized and controlled clinical trial, among multibacillary patients.
Penna GO; Bührer-Sékula S; Kerr LRS; Stefani MMA; Rodrigues LC; de Araújo MG; Ramos AMC; de Andrade ARC; Costa MB; Rosa PS; Gonçalves HS; Cruz R; Barreto ML; Pontes MAA; Penna MLF
PLoS Negl Trop Dis; 2017 Jul; 11(7):e0005725. PubMed ID: 28704363
[TBL] [Abstract][Full Text] [Related]
19. A comparative clinical trial in multibacillary leprosy with long-term relapse rates of four different multidrug regimens.
Fajardo TT; Villahermosa L; Pardillo FE; Abalos RM; Burgos J; Dela Cruz E; Gelber RH
Am J Trop Med Hyg; 2009 Aug; 81(2):330-4. PubMed ID: 19635893
[TBL] [Abstract][Full Text] [Related]
20. Short-term multidrug therapy in multibacillary leprosy--review of 80 cases in two provinces of China (1983-1988).
Li HY; Yu XL; Zhang MS; Duan CX; Huang WB; Zhang SB; Zhu K; Ma JF
Int J Lepr Other Mycobact Dis; 1989 Sep; 57(3):622-7. PubMed ID: 2778368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
